Brucellosis is an infectious disease caused by bacteria. Animals that are most commonly infected include sheep, cattle, goats, pigs, and dogs, among others. These disease can also occur in humans when they are in contact with infected animals or animal products contaminated with bacteria.
Moreover, RB51 Vaccine, S19 Vaccine, B19 Vaccine and Others (45/20 vaccine, SR82 vaccine, etc.) are the type of vaccine used for the brucellosis in animals.
Furthermore, increasing launches of brucellosis vaccination programmes is expected to drive the market growth over the forecast period.
In August 2021, brucella vaccination program was launched at Thoubal, Manipur, India for the control and eradication of brucellosis in female calves of 4-8 months age group.
Increasing prevalence of brucellosis is expected to drive the global brucellosis vaccines market growth over the forecast period. For instance, according to an article published by the National Center for Biotechnology Information, a series of databases relevant to biotechnology and biomedicine, brucellosis is the world’s most widespread zoonotic disease, a type of disease that passes from an animal to a human. The source stated that there are a reported 500,000 cases of human brucellosis each year, globally. However, true incidence is estimated to be 5,000,000 to 12,500,000 cases each year, globally.
According to the same source, brucellosis is recognized as the world’s most common laboratory-acquired infection.
Key features of the study:
- This report provides an in-depth analysis of the global brucellosis vaccines market, market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global brucellosis vaccines market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Merck & Co., Inc., CZ Vaccines, Colorado Serum Company, Indian Immunologicals Ltd., Hester Biosciences Limited, Veterinary Technologies Corporation, Jordan Bio-industries Center, Laboratorios Tornel, Fivet Animal Health and VETAL Animal Health Products Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global brucellosis vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global brucellosis vaccines market
- Global Brucellosis Vaccines Market, By Type:
- RB51 Vaccine
- S19 Vaccine
- B19 Vaccine
- Others (45/20 vaccine, SR82 vaccine, etc.)
- Global Brucellosis Vaccines Market, By Application:
- Others (swine, horses, etc.)
- Global Brucellosis Vaccines Market, By Region:
- North America
- Latin America
- By Country
- Rest of Latin America
- By Country
- Rest of Europe
- Asia Pacific
- By Country
- South Korea
- Rest of Asia Pacific
- Middle East
- By Country
- Rest of Middle East
- By Country/Region
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Competitive Snapshot
- Merck & Co., Inc.*
- Company Overview
- Application Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- CZ Vaccines
- Colorado Serum Company
- Indian Immunologicals Ltd.
- Hester Biosciences Limited
- Veterinary Technologies Corporation
- Jordan Bio-industries Center
- Laboratorios Tornel
- Fivet Animal Health
- VETAL Animal Health Products Inc.
“*” marked represents similar segmentation in other categories in the respective section.